MTHFR and malignant colon neoplasm: Therefore, these results suggest that the reduced MTHFR activity due to Glu429Ala polymorphism may be associated with shorter OS, and thus may be a promising adverse prognostic marker, in early stage colon cancer patients or those patients not treated with 5-FU.